Company Spotlight

Adare Pharma Solutions

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile


Contract Service Directory


Grand River Aseptic Manufacturing





Company Headquarters

140Front Avenue Southwest,
Grand Rapids, MI 49504
United States

Company Description

Grand River Aseptic Manufacturing (GRAM) is a full-service parenteral contract manufacturer, approved by the FDA for aseptic manufacturing, with and without terminal sterilization. We are located in two facilities in downtown Grand Rapids, Michigan. Thanks to our highly skilled, experienced people and a state-of-the-art cleanroom, we are able to take projects from pre-clinical trials through successful commercialism. At GRAM, we treat every client project, regardless of volume or complexity, as if it were our own.

Contract Service Directory

    Related Content

    • cGMP Manufacture | Fill/Finish | Scale-up/Technology Transfer
      Ramping Up COVID-19 Vaccine Fill and Finish Capacity

      Ramping Up COVID-19 Vaccine Fill and Finish Capacity

      As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.
      Kristin Brooks, Contract Pharma 11.03.20

    • The Future of Pharmaceutical Manufacturing: Multi-Product Facility and Equipment Design

      The Future of Pharmaceutical Manufacturing: Multi-Product Facility and Equipment Design

      Join us for a FREE webinar on November 12 at 11:00 AM EST.
      10.26.20

    • Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      CRB Completes Large-Scale Mfg. Facility for GRAM

      CRB Completes Large-Scale Mfg. Facility for GRAM

      GRAM's newest facility was designed to increase its large-scale fill and finish capacity for COVID-19 vaccines and therapeutics.
      Contract Pharma Staff 10.01.20


    • Breaking News | CRO News | Promotions & Moves
      Parexel Adds Experts to Regulatory Consulting Group

      Parexel Adds Experts to Regulatory Consulting Group

      Four new hires from U.S. FDA and MHRA will serve as technical vice presidents
      12.10.19

    • Breaking News | Drug Development | Trials & Filings
      SK Bio Gains FDA Approval for XCOPRI

      SK Bio Gains FDA Approval for XCOPRI

      Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval
      11.25.19

    • A Pharmaceutical Smörgåsbord

      This last issue of the year covers a wide range of pharma topics.
      Tim Wright, Editor 11.20.19


    • Managing Partnerships: Sponsors & CDMOs

      Managing Partnerships: Sponsors & CDMOs

      How to earn – and keep – your spot atop corporations’ short lists of CDMOs.
      Judy Meyers, Sr. Business Development Manager, Grand River Aseptic Manufacturing 11.20.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

    • Grand River

      Grand River's Tom Ross

      GRAM's president and CEO talks with Contract Pharma.
      Contract Pharma Staff


    • AAPS Exhibitor List

      ...
      10.29.19


    • Breaking News | Industry News
      VIDEO: Grand River

      VIDEO: Grand River's Tom Ross

      GRAM's president and CEO talks with Contract Pharma.
      10.04.19



    • Regulatory Affairs
      Quality Metrics Feedback

      Quality Metrics Feedback

      A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholders
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19

    • Breaking News | Industry News
      Grand River Ranked on the Inc. 5000 List for Third Consecutive Year

      Grand River Ranked on the Inc. 5000 List for Third Consecutive Year

      The parenteral CDMO is set to open its third facility in 2020
      08.23.19

    • cGMP Manufacture | Collaborations & Alliances
      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations
      08.01.19

    • Trials & Filings
      FDA Accepts RedHill Biopharma’s NDA for Talicia

      FDA Accepts RedHill Biopharma’s NDA for Talicia

      Commercial launch of H. pylori treatment is planned shortly following potential FDA approval
      07.16.19

    • Extractables and Leachables | Laboratory Testing
      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
      Kristin Brooks, Contract Pharma 07.11.19

    • Trials & Filings
      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor
      06.19.19